✦ LIBER ✦
Comparison of discontinuation risk in patients initiated on lisdexamfetamine dimesylate (LDX) vs. other medications for the treatment of attention deficit/hyperactivity disorder (ADHD): A retrospective claims analysis
✍ Scribed by Setyawan, J.; Hodgkins, P.; Guerin, A.; Gauthier, G.; Cloutier, M.; Wu, E.; Erder, M.H.
- Book ID
- 122912956
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- French
- Weight
- 65 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0222-9617
No coin nor oath required. For personal study only.